Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Panagiota Papanagnou, Panagiotis Baltopoulos & Maria Tsironi. (2015) Marketed nonsteroidal anti-inflammatory agents, antihypertensives, and human immunodeficiency virus protease inhibitors: as-yet-unused weapons of the oncologists’ arsenal. Therapeutics and Clinical Risk Management 11, pages 807-819.
Read now
Read now
E Van der Merwe & A Carboni. (2011) Strategies to improve blood pressure control and cardiovascular outcomes in hypertensive patients. South African Family Practice 53:6, pages 525-532.
Read now
Read now
Articles from other publishers (21)
Daniel Holman, Andrew Bell, Mark Green & Sarah Salway. (2022) Neighbourhood deprivation and intersectional inequalities in biomarkers of healthy ageing in England. Health & Place 77, pages 102871.
Crossref
Crossref
Hongrui Liu, Yiqun Yu, Lu Liu, Chunyan Wang, Nan Guo, Xiaojuan Wang, Xiaoqiang Xiang & Bing Han. (2022) Application of physiologically-based pharmacokinetic/pharmacodynamic models to evaluate the interaction between nifedipine and apatinib. Frontiers in Pharmacology 13.
Crossref
Crossref
Ju-Yeun Lee, Ji Hoon Hong, Sangjun Lee, Seokyung An, Aesun Shin & Sue K. Park. (2022) Binary cutpoint and the combined effect of systolic and diastolic blood pressure on cardiovascular disease mortality: A community-based cohort study. PLOS ONE 17:6, pages e0270510.
Crossref
Crossref
Wanjie Niu, Size Li, Shasha Jin, Xiying Lin, Mengwan Zhang, Weimin Cai, Zheng Jiao & Xiaoqiang Xiang. (2020) Investigating the interaction between nifedipine‐ and ritonavir‐containing antiviral regimens: A physiologically based pharmacokinetic/pharmacodynamic analysis. British Journal of Clinical Pharmacology 87:7, pages 2790-2806.
Crossref
Crossref
Muhammad Asyraf Ismail, Mohd Noor Norhayati & Noraini Mohamad. (2021) Olive leaf extract effect on cardiometabolic profile among adults with prehypertension and hypertension: a systematic review and meta-analysis. PeerJ 9, pages e11173.
Crossref
Crossref
Jane A H Masoli, Joao Delgado, Luke Pilling, David Strain & David Melzer. (2020) Blood pressure in frail older adults: associations with cardiovascular outcomes and all-cause mortality. Age and Ageing 49:5, pages 807-813.
Crossref
Crossref
Daniel Holman, Sarah Salway & Andrew Bell. (2020) Mapping intersectional inequalities in biomarkers of healthy ageing and chronic disease in older English adults. Scientific Reports 10:1.
Crossref
Crossref
Peter M. Mphekgwana, Kotsedi D. Monyeki, Herbert M. Makgopa & Phuti J. Makgae. (2020) Multiple Points Change in the Association of Blood Pressure Subtypes with Anthropometric Indices of Adiposity among Children in a Rural Population. Children 7:4, pages 28.
Crossref
Crossref
Mette Stavnsbo, Turid Skrede, Eivind Aadland, Katrine N. Aadland, Mai Chinapaw, Sigmund A. Anderssen, Lars B. Andersen & Geir K. Resaland. (2019) Cardiometabolic risk factor levels in Norwegian children compared to international reference values: The ASK study. PLOS ONE 14:8, pages e0220239.
Crossref
Crossref
Nadia Solaro, Mara Malacarne, Massimo Pagani & Daniela Lucini. (2019) Cardiac Baroreflex, HRV, and Statistics: An Interdisciplinary Approach in Hypertension. Frontiers in Physiology 10.
Crossref
Crossref
Eric Banan-Mwine Daliri, Fred Kwame Ofosu, Ramachandran Chelliah, Jong-Hak Kim & Deog-Hwan Oh. (2019) Development of a Soy Protein Hydrolysate with an Antihypertensive Effect. International Journal of Molecular Sciences 20:6, pages 1496.
Crossref
Crossref
Diana Thomas Manapurathe, Joseph Vaughan Moxon, Smriti Murali Krishna, Sophie Rowbotham, Frank Quigley, Jason Jenkins, Michael Bourke, Bernard Bourke, Rhondda E. Jones & Jonathan Golledge. (2019) Cohort Study Examining the Association Between Blood Pressure and Cardiovascular Events in Patients With Peripheral Artery Disease. Journal of the American Heart Association 8:6.
Crossref
Crossref
Mingyu ZhangNoel T. MuellerHongjian WangXiumei HongLawrence J. AppelXiaobin Wang. (2018) Maternal Exposure to Ambient Particulate Matter ≤2.5 µm During Pregnancy and the Risk for High Blood Pressure in Childhood. Hypertension 72:1, pages 194-201.
Crossref
Crossref
Mohammad J. AlkhatatbehKhalid K. Abdul-RazzakLubna Q. KhasawnehNesreen A. Saadeh. (2017) High Prevalence of Vitamin D Deficiency and Correlation of Serum Vitamin D with Cardiovascular Risk in Patients with Metabolic Syndrome. Metabolic Syndrome and Related Disorders 15:5, pages 213-219.
Crossref
Crossref
Mariann R. Piano, Adriana Mazzuco, Minkyung Kang & Shane A. Phillips. (2017) Cardiovascular Consequences of Binge Drinking: An Integrative Review with Implications for Advocacy, Policy, and Research. Alcoholism: Clinical and Experimental Research 41:3, pages 487-496.
Crossref
Crossref
. 2016. The Glycemic Index. The Glycemic Index
79
105
.
Rong-Shuang Huang, Yi-Ming Cheng, Xiao-Xi Zeng, Sehee Kim & Ping Fu. (2016) Renoprotective Effect of the Combination of Renin-angiotensin System Inhibitor and Calcium Channel Blocker in Patients with Hypertension and Chronic Kidney Disease. Chinese Medical Journal 129:5, pages 562-569.
Crossref
Crossref
Prince Chikwere, Kwabena Nsiah & Marina A. Tandoh. (2015) Hyperuricaemia and Other Cardiometabolic Risks among Type 2 Diabetes Patients. Trends Journal of Sciences Research 2:4, pages 126-133.
Crossref
Crossref
Claudia Tamar Silva, Jan A. Kors, Najaf Amin, Abbas Dehghan, Jacqueline C. M. Witteman, Rob Willemsen, Ben A. Oostra, Cornelia M. van Duijn & Aaron Isaacs. (2015) Heritabilities, proportions of heritabilities explained by GWAS findings, and implications of cross-phenotype effects on PR interval. Human Genetics 134:11-12, pages 1211-1219.
Crossref
Crossref
Jung-Jin Lee, Chang-Yong Shin, Hong-Joon Park, Wei-Yun Zhang, Yohan Kim, In-Su Kim, Kyu-Hyun Lee & Chang-Seon Myung. (2010) Drug synergism of antihypertensive action in combination of telmisartan with lercanidipine in spontaneous hypertensive rats. Archives of Pharmacal Research 33:9, pages 1411-1418.
Crossref
Crossref
Jean-Jacques Mourad & Sylvain Le Jeune. (2009) Effective Systolic Blood Pressure Reduction with Olmesartan Medoxomil/Amlodipine Combination Therapy. Clinical Drug Investigation 29:6, pages 419-425.
Crossref
Crossref